Annamarie Cruz is a notable inventor based in East Greenbush, NY (US). She has made significant contributions to the field of biochemical filtration, particularly in the detection of endotoxins. Her innovative work is essential for ensuring the safety and efficacy of drug production processes.

Latest Patents

Annamarie holds a patent titled "Methods for evaluating suitability of a biochemical filter." This patent encompasses methods and systems designed to detect the presence of endotoxins in filters. The embodiments of her patent focus on improving in-process controls by identifying undesirable quantities of endotoxins in filters that contain naturally-sourced materials. This detection occurs prior to the use of these filters in the production of formulated drug substances.

Career Highlights

Annamarie Cruz is currently employed at Regeneron Pharmaceuticals, Inc., where she applies her expertise in biochemical research and innovation. Her work at Regeneron is pivotal in advancing the company's mission to develop life-saving therapies.

Collaborations

Annamarie collaborates with esteemed colleagues, including Nathan L. Mao and Bernhard Schilling. These partnerships enhance her research and contribute to the overall success of her projects.

Conclusion

Annamarie Cruz is a pioneering inventor whose work in biochemical filter evaluation is making a significant impact in the pharmaceutical industry. Her dedication to innovation and collaboration continues to drive advancements in drug safety and efficacy.

Profile summary based on public USPTO records.